Mavrokokki, T., Cheng, A., Stein, B. & Goss, A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J. Oral. Maxil. Surg. 65, 415–423 (2007).
Google Scholar
Singh, M. & Gonegandla, G. S. Bisphosphonate induced osteonecrosis of the jaws (BIONJ). J. Maxil. Oral. Surg. 19, 162–167 (2020).
Google Scholar
Falk, W. et al. BRONJ- related jaw bone is associated with increased Dlx-5 and suppressed osteopontin—implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates. Clin. Oral. Invest. 19, 1289–1298 (2015).
Google Scholar
Kilic, E. & Doganay, O. Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review. Gen. Dent. 66, e1–e5 (2018).
Chang, J., Hakam, A. E. & Mccauley, L. K. Current understanding of the pathophysiology of osteonecrosis of the jaw. Curr. Osteoporos. Rep. 16, 584–595 (2018).
Google Scholar
Di Salvatore, M. et al. Barone. Anti‐tumor and anti‐angiogenetic effects of zoledronic acid on human non‐small‐cell lung cancer cell line. Cell Proliferat. 44, 139–146 (2011).
Google Scholar
Loïc, L. et al. Comparative study of neoadjuvant chemotherapy with and without Zometa for management of locally advanced breast cancer with serum VEGF as primary endpoint: the NEOZOL study. Clin. Breast Cancer 18, e1311–e1321 (2018).
Google Scholar
Ferretti, G. et al. Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. Oncology 69, 35–43 (2005).
Google Scholar
James, L. B. et al. Correlation of changes in the mandible and retina/choroid vasculature of a rat model of BRONJ. J. Cranio-Maxill. Surg. 43, 1144–1150 (2015).
Google Scholar
Dan, Z. et al. Tetrahedral framework nucleic acid promotes the treatment of bisphosphonate-related osteonecrosis of the jaws by promoting angiogenesis and M2 polarization. ACS Appl. Mater. Inter. 12, 44508–44522 (2020).
Google Scholar
Kuroshima, S., Nakajima, K., Sasaki, M., Takashi, I. & Sawase, T. Systemic administration of quality- and quantity-controlled pbmncs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice. Stem Cell Res. Ther. 10, 209 (2019).
Google Scholar
Robert, E. M., Yoh, S., Michel, F. & Vishtasb, B. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J. Oral. Maxill. Surg. 63, 1567–1576 (2005).
Google Scholar
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M. & Otto, S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int. J. Oral. Max. Surg. 44, 568–585 (2015).
Google Scholar
Matsumoto, A. et al. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Clin. Oral. Invest. 21, 1–8 (2017).
Google Scholar
Sao-Shen, L. et al. Immediate hyperbaric oxygen after tooth extraction ameliorates bisphosphonate-related osteonecrotic lesion in rats. J. Periodontol. 90, 1449–1456 (2019).
Google Scholar
Voss, P. J. et al. Treatment of stage ii medication-related osteonecrosis of the jaw with neurectomy and autologous bone marrow mesenchymal stem cells. Odontology 105, 484–493 (2017).
Google Scholar
Cardoso, C. L., Curra, C., Curi, M. M., Matsumoto, M. A. & Jnior, O. F. Treatment of bisphosphonate-related osteonecrosis using platelet-rich plasma: microtomographic, microscopic, and immunohistochemical analyses. Braz. Oral. Res. 33, e050 (2019).
Google Scholar
Julie, G. Angiogenesis in fracture repair. Clin. Orthop. Relat. R. 355, 82–89 (1998).
Hu, K. & Olsen, B. R. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 91, 30–38 (2016).
Google Scholar
D’Andrea, L. et al. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc. Natl Acad. Sci. USA 102, 14215–14220 (2005).
Google Scholar
Santulli, G. et al. In vivo properties of the proangiogenic peptide QK. J. Trans. Med. 7, 41–50 (2009).
Google Scholar
Finetti, F., Basile, A., Capasso, D., Gaetano, S. D. & D’Andrea, L. D. Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis. Biochem. Pharmacol. 84, 303–311 (2012).
Google Scholar
Pensa, N. W., Curry, A. S., Reddy, M. S. & Bellis, S. L. Sustained delivery of the angiogenic QK peptide through the use of polyglutamate domains to control peptide release from bone graft materials. J. Biomed. Mater. Res. A 107, 2764–2773 (2019).
Google Scholar
Wenjuan, M. et al. Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv. Mater. e2109609 (2022).
Bowen, Z. et al. Facilitating in-situ tumor imaging with a tetrahedral DNA framework-enhanced hybridization chain reaction probe. Adv. Funct. Mater. 2109728 (2022).
Mi, Z. et al. A DNA nanostructure-based neuroprotectant against neuronal apoptosis via inhibiting toll-like receptor 2 signaling pathway in acute ischemic stroke. ACS Nano. 16, 1456–1470 (2022).
Google Scholar
Yuhao, L. et al. Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation. Nano Lett. 20, 3602–3610 (2020).
Google Scholar
Mengting, L. et al. Enhanced penetrability of a tetrahedral framework nucleic acid by modification with iRGD for DOX-targeted delivery to triple negative breast cancer. ACS Appl. Mater. Inter. 13, 25825–25835 (2021).
Google Scholar
Wood, J. et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J. Pharmacol. Exp. Ther. 302, 1055–1061 (2002).
Google Scholar
Pabst, A. M., Ziebart, T., Ackermann, M., Konerding, M. A. & Walter, C. Bisphosphonates’ antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D matrigel assay. Clin. Oral. Invest. 18, 1015–1022 (2014).
Google Scholar
Dan, Z. et al. Tetrahedral DNA nanostructure promotes endothelial cell proliferation, migration, and angiogenesis via notch signaling pathway. ACS Appl. Mater. Inter. 10, 37911–37918 (2018).
Google Scholar
Shiyu, L. et al. Antioxidative and angiogenesis-promoting effects of tetrahedral framework nucleic acids in diabetic wound healing with activation of the Akt/Nrf2/HO-1 pathway. ACS Appl. Mater. Inter. 12, 11397–11408 (2020).
Google Scholar
Dan, Z. et al. Angiogenic aptamer-modified tetrahedral framework nucleic acid promotes angiogenesis in vitro and in vivo. ACS Appl. Mater. Inter. 13, 29439–29449 (2021).
Google Scholar
Potente, M., Gerhardt, H. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis. Cell 146, 873–887 (2011).
Google Scholar
Tao, Z. et al. Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat. Protoc. 15, 2728–2757 (2020).
Google Scholar
Tao, Z., Taoran, T. & Yunfeng, L. Functionalizing framework nucleic acid-based nanostructures for biomedical application. Adv. Mater. e2107820 (2021).
Yun, W. et al. Tetrahedral framework nucleic acids can alleviate taurocholate-induced severe acute pancreatitis and its subsequent multi-organ injury in mice. Nano Lett. 22, 1759–1768 (2022).
Google Scholar
Jun, L. et al. Repair of infected bone defect with clindamycin-tetrahedral DNA nanostructure complex-loaded 3D bioprinted hybrid scaffold. Chem. Eng. J. 435, 134855 (2022).
Google Scholar
Mei, Z. et al. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty. Arthritis Bioact. Mater. 8, 368–380 (2022).
Xin, Q. et al. Tetrahedral framework nucleic acids-based delivery of microRNA-155 inhibits choroidal neovascularization by regulating the polarization of macrophages. Bioact. Mater. 14, 134–144 (2022).
Google Scholar
Silva, M. L. et al. Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy—histomorphometric and immunohistochemical analysis. Clin. Oral. Invest. 21, 199–210 (2017).
Google Scholar
Rupel, K. et al. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral. Oncol. 50, 1049–1057 (2014).
Google Scholar
Rodolfo, M. et al. Conservative surgical treatment of bisphosphonate-related osteonecrosis of the jaw with Er,Cr:YSGG laser and platelet-rich plasma: a longitudinal study. Biomed. Res. Int. 2018, 1–10 (2018).
Martins, M. A. T. et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral. Oncol. 48, 79–84 (2012).
Google Scholar
Longo, F. et al. Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Inter. J. Dent. 2014, 1–7 (2014).
Google Scholar
Maluf, G., Caldas, R. J., Fregnani, E. R. & Santos, P. A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants. Inter. J. Implant Dent. 5, 1–6 (2019).
Mohamed, H. A. M., Nielsen, C. E. N. & Schiodt, M. Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. a report of 7 cases from the Copenhagen cohort. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 125, 157–163 (2017).
Google Scholar
Xiaoyuan, J. et al. Protein-mimicking nanoparticles for a cellular regulation of homeostasis. ACS Appl. Mater. inter, 13, 31331–31336 (2021).
Google Scholar
Yanfeng, Z. et al. An organelle‐specific nanozyme for diabetes care in genetically or diet‐induced models. Adv. Mater., 32, 2003708 (2020).
Google Scholar
